Y Intercept Hong Kong Ltd Takes Position in GE HealthCare Technologies Inc. $GEHC

Y Intercept Hong Kong Ltd acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 15,361 shares of the company’s stock, valued at approximately $1,154,000.

Several other large investors have also recently bought and sold shares of GEHC. Dodge & Cox lifted its holdings in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares during the last quarter. Norges Bank acquired a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth about $468,120,000. Holocene Advisors LP lifted its stake in GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after purchasing an additional 2,581,522 shares during the last quarter. Menora Mivtachim Holdings LTD. acquired a new position in GE HealthCare Technologies in the second quarter valued at approximately $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new position in GE HealthCare Technologies in the second quarter valued at approximately $58,388,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $78.97 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a market capitalization of $35.97 billion, a price-to-earnings ratio of 16.32, a PEG ratio of 2.38 and a beta of 1.08. The company has a 50-day simple moving average of $82.63 and a 200-day simple moving average of $77.37. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.14 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a report on Friday, January 9th. Barclays assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Evercore ISI reiterated an “outperform” rating and set a $95.00 target price on shares of GE HealthCare Technologies in a research report on Monday, January 5th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, Wells Fargo & Company dropped their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of “Hold” and an average price target of $90.33.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.